Shin Poong Pharm.Co.Ltd.
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial dru… Read more
Shin Poong Pharm.Co.Ltd. (019170) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.034x
Based on the latest financial reports, Shin Poong Pharm.Co.Ltd. (019170) has a cash flow conversion efficiency ratio of 0.034x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.94 Billion) by net assets (₩264.20 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shin Poong Pharm.Co.Ltd. - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Shin Poong Pharm.Co.Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shin Poong Pharm.Co.Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shin Poong Pharm.Co.Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Earth-Panda Advanced Magnetic Material Co Ltd
SHG:688077
|
0.006x |
|
Hailun Piano Co Ltd
SHE:300329
|
0.006x |
|
BETTERWARE DE MEXICO SAPI
F:BM0
|
N/A |
|
Csd Water Service Co Ltd
SHG:603903
|
0.098x |
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
-0.092x |
|
Sam Hwa Capaci
KO:001820
|
0.011x |
|
Acast AB
ST:ACAST
|
0.057x |
|
POSCO M-TECH Co. Ltd
KQ:009520
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Shin Poong Pharm.Co.Ltd. (2004–2024)
The table below shows the annual cash flow conversion efficiency of Shin Poong Pharm.Co.Ltd. from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩258.09 Billion | ₩-15.15 Billion | -0.059x | +35.91% |
| 2023-12-31 | ₩270.78 Billion | ₩-24.81 Billion | -0.092x | -14.59% |
| 2022-12-31 | ₩330.76 Billion | ₩-26.44 Billion | -0.080x | +60.09% |
| 2021-12-31 | ₩354.56 Billion | ₩-71.03 Billion | -0.200x | -473.78% |
| 2020-12-31 | ₩374.33 Billion | ₩20.06 Billion | 0.054x | -42.08% |
| 2019-12-31 | ₩209.13 Billion | ₩19.35 Billion | 0.093x | -40.11% |
| 2018-12-31 | ₩207.48 Billion | ₩32.05 Billion | 0.154x | +219.87% |
| 2017-12-31 | ₩210.11 Billion | ₩10.15 Billion | 0.048x | -44.76% |
| 2016-12-31 | ₩216.85 Billion | ₩18.96 Billion | 0.087x | +72.25% |
| 2015-12-31 | ₩194.86 Billion | ₩9.89 Billion | 0.051x | +20285.40% |
| 2014-12-31 | ₩191.51 Billion | ₩-48.16 Million | 0.000x | -100.42% |
| 2013-12-31 | ₩190.79 Billion | ₩11.45 Billion | 0.060x | -63.21% |
| 2012-12-31 | ₩188.73 Billion | ₩30.79 Billion | 0.163x | +2.16% |
| 2011-12-31 | ₩179.86 Billion | ₩28.73 Billion | 0.160x | +111.50% |
| 2010-12-31 | ₩150.39 Billion | ₩11.36 Billion | 0.076x | +11.76% |
| 2009-12-31 | ₩145.31 Billion | ₩9.82 Billion | 0.068x | -63.33% |
| 2008-12-31 | ₩127.93 Billion | ₩23.57 Billion | 0.184x | +114.71% |
| 2007-12-31 | ₩113.81 Billion | ₩9.77 Billion | 0.086x | -14.81% |
| 2006-12-31 | ₩106.28 Billion | ₩10.71 Billion | 0.101x | +99.59% |
| 2005-12-31 | ₩97.65 Billion | ₩4.93 Billion | 0.050x | -57.97% |
| 2004-12-31 | ₩87.36 Billion | ₩10.49 Billion | 0.120x | -- |